Pathogenesis, prevention, and therapy of staphylococcal prosthetic infections

Current Clinical Topics in Infectious Diseases

Volumn , Issue 21, 2001, Pages 252-270

  Lew, Daniel ^a   Schrenzel, Jacques ^a   François, Patrice ^a   Vaudaux, Pierre ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; BIOPROSTHESIS; FOREIGN BODY REACTION; HUMAN; MICROBIOLOGY; REVIEW; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOPROSTHESIS; FOREIGN-BODY REACTION; HUMANS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 0035225348     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (139)

1. Herrmann M, Vaudaux P, Pittet D, et al. Fibronectin, fibrinogen and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158: 693-701.
2. Herrmann M, Hartleib J, Kehrel B, et al. Interaction of von Willebrand factor with Staphylococcus aureus. J Infect Dis 1997;176: 984-991.
3. Lew DP, Zubler R, Vaudaux P, et al. Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions. J Clin Invest 1979;63:326-334.
4. Herrmann M, Lai QJ, Albrecht RM, et al. Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis 1993;167:312-322.
5. Herrmann M, Suchard SJ, Boxer LA, et al. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991;59:279-288.
6. Grinnell F, Feld M, Minter D. Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin). Cell 1980;19:517-525.
7. Dziewanowska K, Patti JM, Deobald CF, et al. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun 1999;67:4673-4678.
8. Cheung AL, Krishnan M, Jaffe EA, Fischetti VA. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest 1991;87: 2236-2245.
9. 1. Cell Microbiol 1999;1:101-117.
10. Dougherty SH, Simmons RL. Endogenous factors contributing to prosthetic device infections. Infect Dis Clin N Am 1989;3:199-209.
11. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-532.
12. Navarre WW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 1999;63:174-229.
13. Westerlund B, Korhonen TK. Bacterial proteins binding to the mammalian extracellular matrix. Mol Microbiol 1993;9:687-694.
14. Patti JM, Hook M. Microbial adhesins recognizing extracellular matrix macromolecules. Curr Opin Cell Biol 1994;6:752-758.
15. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994;48:585-617.
16. Gillaspy AF, Patti JM, Smeltzer MS. Transcriptional regulation of the Staphylococcus aureus collagen adhesion gene, cna. Infect Immun 1997;65:1536-1540.
17. Switalski LM, Patti JM, Butcher W, et al. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol Microbiol 1993;7:99-107.
18. Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol Lett 1994; 118:199-205.
19. Francois P, Schrenzel J, Stoermann-Chopard C, et al. Identification of plasma proteins adsorbed on hemodialysis tubing promoting Staphylococcus aureus adhesion. J Lab Clin Med 2000;135(1):32-42.
20. Vaudaux PE, Francois P, Proctor RA, et al. Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun 1995;63: 585-590.
21. Vaudaux P, Pittet D, Haeberli A, et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis 1993;167:633-641.
22. Vaudaux P, Suzuki R, Waldvogel FA, et al. Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 1984;150:546-553.
23. Casolini F, Visai L, Joh D, et al. Antibody response to fibronectin-binding adhesin FnbpA in patients with Staphylococcus aureus infections. Infect Immun 1998;66:5433-5442.
24. Nilsson IM, Patti JM, Bremell T, et al. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest 1998;101:2640-2649.
25. Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995;63: 4738-4743.
26. Patti JM, Bremell T, Krajewska-Pietrasik D, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994;62:152-161.
27. Mazmanian SK, Liu G, Jensen ER, et al O. Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci USA 2000;97:5510-5515.
28. Watanakunakom C. Increasing importance of intravascular device-associated Staphylococcus aureus endocarditis [editorial; comment]. Clin Infect Dis 1999;28:115-116.
29. Francois P, Vaudaux P, Foster TJ, Lew PD. Host-bacteria interactions in foreign body infections. Infect Control Hosp Epidemiol 1996;17: 514-520.
30. Wadstrom T. Molecular aspects on pathogenesis of wound and foreign body infections due to staphylococci [123 refs]. Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene-Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology 1987;266:191-211.
31. Francois P, Vaudaux P, Lew PD. Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann Vascul Surg 1998;12:34-40.
32. Cheung AL, Eberhardt KJ, Chung E, et al. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest 1994;94:1815-1822.
33. Alston WK, Elliott DA, Epstein ME, et al. Extracellular matrix heparan sulfate modulates endothelial cell susceptibility to Staphylococcus aureus. J Cell Physiol 1997;173:102-109.
34. Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988;10: 103-110.
35. Miller MH, Edberg SC, Mandel LJ, et al. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob Agent Chemotherap 1980; 18:722-729.
36. Lambe DWJ, Ferguson KP, Mayberry-Carson KJ, et al. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthopacd Rel Res 1991;285-294.
37. Buxton TB, Horner J, Hinton A, Rissing JP. In vivo glycocalyx expression by Staphylococcus aureus phage type 52/52A/80 in S. aureus osteomyelitis. J Infect Dis 1987;156:942-946.
38. Mempel M, Gunther B, Muller E, Gruter L. Detection and measurement of Staphylococcus epidermidis slime using an ELISA technique. Microbiol Immunol 1996;40:115-119.
39. Hussain M, Hastings JG, White PJ. Isolation and composition of the extracellular slime made by coagulase-negative staphylococci in a chemically defined medium. J Infect Dis 1991;163: 534-541.
40. Christensen GD, Baldassarri L, Simpson WA. Infections associated with indwelling medical devices, 2nd ed. Washington, DC: ASM Press, 1994:45-78.
41. Nilsson M, Frykberg L, Flock J-I, et al. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun 1998;66:2666-2673.
42. Francois P, Letourneur D, Lew DP, et al. Inhibition by heparin and derivatized dextrans of Staphylococcus epidermidis adhesion to in vitro fibronectin-coated or explanted polymer surfaces. J Biomater Sci Polym Ed 1999;10:1207-1221.
43. Heilmann C, Hussain M, Peters G, Götz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol 1997;24:1013-1024.
44. Heilmann C, Gerke C, Perdreau-Remington F, Gotz F. Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun 1996;64:277-282.
45. Mack D, Fischer W, Leopold K, et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear β-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996;178:175-183.
46. Ziebuhr W, Heilmann C, Gotz F, et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun 1997;65:890-896.
47. Schumacher-Perdreau F, Heilmann C, Peters G, et al. Comparative analysis of a biofilmforming Staphylococcus epidermidis strain and its adhesion-positive, accumulation-negative mutant M7. FEMS Microbiol Lett 1994;117:71-78.
48. Hussain M, Herrmann M, von Eiff C, et al. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun 1997; 65:519-524.
49. Sanford BA, de Feijter AW, Wade MH, Thomas VL. A dual fluorescence technique for visualization of Staphylococcus epidermidis biofilm using scanning confocal laser microscopy. J Ind Microbiol 1996;16:48-56.
50. Gray KM. Intercellular communication and group behavior in bacteria [30 refs]. Trend Microbiol 1997;5:184-188.
51. Dunny GM, Leonard BA. Cell-cell communication in gram-positive bacteria [130 refs]. Annu Rev Microbiol 1997;51:527-564.
52. Mayville P, Ji G, Beavis R, et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci USA 1999;96: 1218-1223.
53. Novick RP, Muir TW. Virulence gene regulation by peptides in staphylococci and other Gram-positive bacteria. Curr Opin Microbiol 1999;2:40-45.
54. Dankert J, Hogt AH, Feijen J. Biomedical polymers: bacterial adhesion, colonization and infection. CRC Critical Rev Biocompatib 1986;2: 219-301.
55. Leonard BA, Hirt H, Dunny GM. Regulation of aggregation substance expression by bacterial and host factors. Adv Exp Med Biol 1997;418: 785-787.
56. Sakata N, Usui Y, Kogure T. Extracellular product(s) of Staphylococcus aureus stimulate their own growth. Zentralbl Bakteriol 1999;289: 339-345.
57. Ji G, Beavis RC, Novick RP. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci USA 1995;92:12,055-12,059.
58. Cheung AL, Bayer MG, Heinrichs JH. sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus. J Bacteriol 1997;179:3963-3971.
59. Novick RP, Projan SJ, Komblum J, et al. The agr P2 operon: an autocatalytic sensory trausduction system in Staphylococcus aureus. Mol Gen Genet 1995;248:446-458.
60. Kleerebezem M, Quadri LE, Kuipers OP, de Vos WM. Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria [38 refs]. Mol Microbiol 1997;24:895-904.
61. Cheung AL, Koomey JM, Butler CA, et al. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci USA 1992;89: 6462-6466.
62. Recsci P, Kreiswirth B, O'Reilly M, et al. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 1986; 202:58-61.
63. Proctor RA, Kahl B, von Eiff C, et al. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 1998;27(suppl 1):S68-S74.
64. Balaban N, Goldkorn T, Nhan RT, et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 1998;280:438-440.
65. Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 1997;276:2027-2030.
66. Lebeau C, Vandenesch F, Greenland T, et al. Coagulase expression in Staphylococcus aureus is positively and negatively modulated by an agrdependent mechanism. J Bacteriol 1994;176: 5534-5536.
67. Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280: 295-298.
68. Williams I, Paul F, Lloyd D, et al. Flow cytometry and other techniques show that Staphylococcus aureus undergoes significant physiological changes in the early stages of surface-attached culture. Microbiology 1999;145(pt 6):1325-1333.
69. Darouiche RO, Dhir A, Miller AJ, et al. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 1994:170:720-723.
70. Vroom JM, De Grauw KJ, Gerritsen HC, et al. Depth penetration and detection of pH gradients in biofilms by two-photon excitation microscopy. Appl Environ Microbiol 1999;65:3502-3511.
71. von Eiff C, Heilmann C, Proctor RA, et al. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 1997;179:4706-4712.
72. Brown MR, Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988;22: 777-780.
73. Amorena B, Gracia E, Monzon M, et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 1999;44:43-55.
74. Gracia E, Lacleriga A, Monzon M, et al. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. J Surg Res 1998;79:146-153.
75. Isiklar ZU, Darouiche RO, Landon GC, Beck T. Efficacy of antibiotics alone for orthopaedic device related infections. Clin Orthopaed Rel Res 1996:184-189.
76. Proctor RA, Van Langevelde P, Kristjansson M, et al. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995;20:95-102.
77. Trafny EA. Susceptibility of adherent organisms from Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from bum wounds to antimicrobial agents. Int J Antimicrob Agents 1998;10:223-228.
78. Chuard C, Vaudaux P, Waldvogel FA, Lew DP. Susceptibility of Staphylococcus aureus growing on fibronectin-coatcd surfaces to bactericidal antibiotics. Antimicrob Agent Chemotherap 1993;37:625-632.
79. Chuard C, Vaudaux PE, Proctor RA, Lew DP. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother 1997;39:603-608.
80. De Beer D, Stoodley P, Roe F, Lewandowski Z. Effects of biofilm structures on oxygen distribution and mass transport. Biotech Bioeng 1994;43: 1131-1138.
81. De Beer D, Stoodley P, Lewandowski Z. Liquid flow in heterogeneous biofilms. Biotech Bioeng 1994;44:636-641.
82. Dunne WM Jr, Mason EO Jr, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agent Chemotherap 1993;37:2522-2526.
83. Regassa LB, Betley MJ. Alkaline pH decreases expression of the accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol 1992;174: 5095-5100.
84. Xu KD, Stewart PS, Xia F, et al. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ Microbiol 1998;64:4035-4039.
85. Tunney MM, Patrick S, Gorman SP, et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 1998;80:568-572.
86. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984;73: 1191-1200.
87. Hermann M, Jaconi ME, Dahlgren C, et al. Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms. J Clin Invest 1990;86:942-951.
88. Vaudaux P, Zulian G, Huggler E, Waldvogel FA. Attachment of Staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immun 1985;50:472-477.
89. Vaudaux P, Grau GE, Huggler E, et al. Contribution of tumor necrosis factor to host defense against staphylococci in a guinea pig model of foreign body infections. J Infect Dis 1992;166: 58-64.
90. Peters G, Gray ED, Johnson GM. Infections associated with indwelling medical devices. Washington, DC: American Society for Microbiology, 1989:61-74.
91. Finlay BB, Cossart P. Exploitation of mammalian host cell functions by bacterial pathogens. Science 1997;276:718-725.
92. Ogawa SK, Yurberg ER, Hatcher VB, et al. Bacterial adherence to human endothelial cells in vitro. Infect Immun 1985;50:218-224.
93. Bayles KW, Wesson CA, Lion LE, et al. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun 1998;66:336-342.
94. Usui A, Murai M, Seki K, et al. Conspicuous ingestion of Staphylococcus aureus organisms by murine fibroblasts in vitro. Microbiol Immunol 1992;36:545-550.
95. Bisno AL, Waldvogel FA. Infections associated with indwelling medical devices, 2nd ed. Washington, DC: ASM Press, 1994:1-398.
96. Lucet JC, Herrmann M, Rohner P, et al. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemotherap 1990; 34:2312-2317.
97. Vaudaux P, Lew DP, Waldvogel FA. Host factors predisposing to foreign body infections. In: Bisno AL, Waldvogel FA, eds. Infections associated with indwelling medical devices. 2nd ed. American Society for Microbiology, 1989:3-26.
98. Vaudaux P. Phenotypic antibiotic tolerance of Staphylococcus aureus in implant-related infections: relationship with in vitro colonization of artificial surfaces. Drug Resistance Updates 1998; 1:352-357.
99. Schaad HJ, Chuard C, Vaudaux P, et al. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1994;38:1703-1710.
100. Cagni A, Chuard C, Vaudaux PE, et al. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemotherap 1995;39:1655-1660.
101. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-1133.
102. Greenberg RN, Tice AD, Marsh PK, et al. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis. Am J Med 1987;82:266-269.
103. Chuard C, Lucet EC, Rohner P, et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991;163:1369-1373.
104. Brause BD. Infected Orthopedic Protheses. In: Bisno AL, Waldvogel FA, eds. Infections associated with indwelling medical devices. 2nd ed. American Society for Microbiology, 1989:111-127.
105. Salvati EA, Small RD, Brause BD, Pellicci PM. Infections associated with prosthetic devices. Boca Raton, FL: CRC Press, 1984:181-218.
106. Fitzgerald RH Jr. Total hip arthroplasty sepsis prevention and diagnosis. Orthop Clin N Am 1992;23:259-264.
107. Cuckler JM, Star AM, Alavi A, Noto RB. Diagnosis and management of the infected total joint arthroplasty. Orthop Clin N Am 1992;22:523-530.
108. Rasul AT Jr, Tsukayama D, Gustilo RB. Effect of time of onset and depth of infection on the outcome of total knee arthroplasty infections. Clin Orthop 1991:98-104.
109. Sanderson PJ. Infection in orthopaedic implants. J Hosp Infect 1991;18(suppl A):367-375.
110. Gordon SM, Culver DH, Simmons BP, Jarvis WR. Risk factors for wound infections after total knee arthroplasty. Am J Epidemiol 1990;131: 905-916.
111. Whyte W, Hodgson R, Tinkler J, Graham J. The isolation of bacteria of low pathogenicity from faulty orthopaedic implants. J Hosp Infect 1981; 2:219-230.
112. Malghem J, Mosseray A, Vande Berg B, et al. Radiologic aspects of the loosening of cemented hip prostheses: mechanical, septic or granulomatous etiology? J Belge Radiol 1997;80:173-184.
113. Alazraki NP. Diagnosing prosthetic joint infection. J Nucl Med 1990-.31-.1955-1957.
114. Palestro CJ, Swyer AJ, Kim CK, Goldsmith SJ. Infected knee prosthesis: diagnosis with In-111 leukocyte, Tc-99m sulfur colloid, and Tc-99m MDP imaging. Radiology 1991;179:645-648.
115. Lopitaux R, Levai JP, Raux P, et al. [Value of puncture-arthrography in the diagnosis of infection of total hip arthroplasty.] Interet de la ponction-arthrographie de hanche dans le diagnostic d'infection sur prothese totale. Rev Chir Orthop Reparatrice Appar Mot 1992;78:34-37.
116. Roberts P, Walters AJ, McMinn DJW. Diagnosing infection in hip replacements. The use of fine-needle aspiration and radiometric culture. J Bone Joint Surg 1992;74B:265-269.
117. Perdreau-Remington F, Rank DR, Lopez FA, Goodmann SB. Identifying multiple isolates throuhg the comparison of genomic DNAs in a patient with infected hip prosthesis. West J Med 1998;168:128-130.
118. Tshefu K, Zimmerli W, Waldvogel FA. Shortterm administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis 1983;5(suppl):S474-S480.
119. Waldvogel FA, Vaudaux P, Pittet D, Lew DP. Perioperative antibiotic prophylaxis of wound and foreign body infections: microbial factors affecting efficacy. Rev Infect Dis 1991;13(suppl): S782-S789.
120. Hirsehmann JV. Infections associated with prosthetic devices. Boca Raton, FL: CRC Press, 1984:269-278.
121. Lidwell OM, Lowbury EJL, Whyte W, et al. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomized study. Br Med J 1982;285:10-14.
122. Lidwell OM, Elson RA, Lowbury EJ, et al. Ultraclean air and antibiotics for prevention of postoperative infection. A multicenter study of 8,052 joint replacement operations. Acta Ortliop Scand 1987;58:4-13.
123. Klenerman L, Seal D, Sullens K. Combined prophylactic effect of ultraclean air and cefuroxime for reducing infection in prosthetic surgery. Acta Orthop Belg 1991;57:19-24.
124. Norden CW. Antibiotic prophylaxis in orthopedic surgery. Rev Infect Dis 1991;13(suppl): S842-S846.
125. James PJ, Butcher IA, Gardner ER, Hamblen DL. Methicillin-resistant staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg [Br] 1994;76B:725-727.
126. Glenny A, Song F. Antimicrobial prophylaxis in total hip replacement: a systematic review. Health Technol Assess 1999;3:1-57.
127. Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register, 1987 to 1995. J Bone Joint Surg [Br] 1997;79:590-595.
128. Buchholz HW, Elson RA, Heinert K. Antibioticloaded acrylic cement: current concepts. Clin Orthop 1984:96-108.
129. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Long-term followup. Clin Orthop 1995: 202-207.
130. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998;80:961-968.
131. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997;24:914-919.
132. Drancourt M, Stein A, Argenson JN, et al. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993;37:1214-1218.
133. Zimmerli W, Widmer AF, Blatter M, et al. Role of rifampin for treatment of orthopedic implantrelated staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998;279:1537-1541.
134. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol 1994;11:237-248.
135. Ni Eidhin D, Perkins S, Francois P, et al. Clumping factor B (CIfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol 1998;30:245-257.
136. Jonsson K, Signäs C, Muller HP, Lindberg M. Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene. Eur J Biochem 1991;202: 1041-1048.
137. Signas C, Raucci G, Jonsson K, et al. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci USA 1989;86:699-703.
138. Park PW, Rosenbloom J, Abrams WR, Mccham RP. Molecular cloning and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus. J Biol Chem 1996;271:15, 803-15,809.
139. Tung H, Guss B, Hellman U, et al. A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J 2000;345:611-619.